Alan Dunton

Alan Dunton

Direktor/Vorstandsmitglied bei CORMEDIX INC.

Vermögen: 595 501 $ am 31.05.2026

71 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
13.04.2026 40’250 ( 0.05% ) 339 710 $ 31.05.2026
09.12.2025 14’081 ( 0.79% ) 197 416 $ 31.05.2026
30.06.2025 146’288 ( 0.05% ) 57 889 $ 31.05.2026
30.04.2026 802 ( 0.02% ) 486 $ 31.05.2026

Aktive Positionen von Alan Dunton

UnternehmenPositionBeginn
CORMEDIX INC. Direktor/Vorstandsmitglied 01.03.2019
ORAGENICS, INC. Direktor/Vorstandsmitglied 01.04.2011
PALATIN TECHNOLOGIES, INC. Direktor/Vorstandsmitglied 22.06.2011
RECCE PHARMACEUTICALS LTD Direktor/Vorstandsmitglied 14.07.2020
Direktor/Vorstandsmitglied 01.10.2018
Direktor/Vorstandsmitglied 01.01.2007

Ehemalige bekannte Positionen von Alan Dunton

UnternehmenPositionEnde
REGENEUS LTD Direktor/Vorstandsmitglied 25.02.2021
Technik-/Wissenschafts-/F&E-Leiter 01.03.2018
ADHERA THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter 21.02.2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Alan Dunton im Detail an

Ausbildung von Alan Dunton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

71

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Alan Dunton
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT